Recursion Partners with Genentech to Advance First Validated Neuro Target Discovered Through AI Map - Genetic Engineering and Biotechnology News

A biotech company and pharmaceutical giant partnered to develop a new drug target for neurological diseases using AI-powered analysis. This matters because it shows AI is accelerating real medical discoveries that could lead to new treatments.